Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

0(0%)

Results Posted

50%(3 trials)

Phase Distribution

Ph phase_4

50%

Ph phase_2

13%

Ph phase_3

38%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 2Efficacy & side effects

1(12.5%)

Phase 3Large-scale testing

3(37.5%)

Phase 4Post-market surveillance

4(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Other(2)

Detailed Status

Completed6

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (12.5%)

Phase 33 (37.5%)

Phase 44 (50.0%)

Trials by Status

completed675%

unknown225%

Recent Activity

0 active trials

Showing 5 of 8

completedphase_3

Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)

NCT00423488

completedphase_3

Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial.

NCT03435744

unknownphase_4

NIRS to Diagnose SAMS

NCT03653663

unknownphase_4

Trial of Simvastatin in Amnestic Mild Cognitive Impairment (MCI) Patients

NCT00842920

completedphase_4

Methotrexate and Statins With Methotrexate Alone in the Treatment of Rheumatoid Arthritis

NCT04177173

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT00423488Phase 3

Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)

Completed

NCT03435744Phase 3

Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial.

Completed

NCT03653663Phase 4

NIRS to Diagnose SAMS

Unknown

NCT00842920Phase 4

Trial of Simvastatin in Amnestic Mild Cognitive Impairment (MCI) Patients

Unknown

NCT04177173Phase 4

Methotrexate and Statins With Methotrexate Alone in the Treatment of Rheumatoid Arthritis

Completed

NCT03150459Phase 2

Simvastatin Plus Rifaximin in Decompensated Cirrhosis

Completed

NCT01674712Phase 3

A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease

Completed

NCT00125593Phase 4

Study of Heart and Renal Protection

Completed

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8